Aveanna Healthcare Holdings Inc.

AVAH Healthcare Medical Care Facilities

Aveanna Healthcare Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 20.2% from fiscal 2024.

Revenue
+13.7%
EPS
+46.2%
Free cash flow
+57.9%
Total debt
+1.07%

Quarter to June 2026, against a year earlier

13.68 0.55 −3.87%
Market cap
$3.0B
P/E
10.5×
Fwd P/E
18.3×
Dividend yield
—
F-score
7/9
Altman Z
1.45
Beneish M
−2.10
Dividend safety
n/a

Aveanna Healthcare Holdings Inc. (AVAH) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Aveanna Healthcare Holdings Inc. (AVAH) trades at a EV/EBITDA of 14.1×. Over the past ten years it has ranged from 8.5× (April 2026) to 24.1× (June 2021); the current reading is higher than 47% of that period. That is above the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 10.1× (20.70%)
FY2024 12.7× (1.55%)
FY2023 12.9× (33.20%)
FY2022 19.4× (5.93%)
FY2021 20.6× (10.73%)
FY2020 23.1× 0.00%
FY2019 23.1× 0.00%
FY2018 23.1× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 10.5× 21.83%
Mar 2026 8.6× (14.68%)
Dec 2025 10.1× (15.40%)
Sep 2025 11.9× 22.70%
22 more quarters

Against its own ten years

Low 8.5× High 24.1×
Ten-year median 14.6×
Current reading's percentile 47

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on AVAH